In 2000, nearly 200 research studies were active through the Health Research Center (HRC). In addition, more than 120 cancer treatment and prevention studies were available to Park Nicollet patients through the Metro-Minnesota Community Clinical Oncology Program (CCOP).

HRC received a grant from The Robert Wood Johnson Foundation for the Risk Adjustment Impact Study. The study will research health-based risk adjustment implementation and measure its impact on managed care organizations.

The Board of Governors of the American College of Healthcare Executives appointed Jinnet Fowles, PhD, vice president, research, to a three-year term on its Association for Health Services Research/Health Administration Press Series Editorial

International Diabetes Center (IDC) contributed more than 18 posters and presentations at the International Diabetes Federation Congress meeting in Mexico City. While in Mexico, IDC staff hosted Staged Diabetes Management: Worldwide Outcomes 2000. Participants representing a dozen countries shared clinical outcomes and new implementation models.

The Minnesota Partnership for Action Against Tobacco awarded IDC and the University of Minnesota a three-year grant to integrate smoking cessation interventions into the Type 2 Diabetes BASICS group education program. The study will evaluate the impact on cardiovascular risk factors, as well as the health and economic impacts, of smoking cessation in people with diabetes.

The Agency for Healthcare Research and Quality awarded HRC a grant to support "Consumer Response to Report Cards about Care Systems." This study assesses the impact on employees of report cards that compare the quality of care systems. The study is jointly funded by Buyers Health Care Action Group and involves six of its member companies.

Park Nicollet staff published more than 100 articles in leading national journals. Richard Bergenstal, MD; Mary Johnson, RN, BS, CDE; David Kendall, MD; and Martha Spencer, MD, are the authors of "Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy." New England Journal of Medicine 2000;342:381-9. Mary Jo Nissen, PhD, is the lead author of "Breast carcinoma after cancer at another site: method of detection, tumor characteristics and surgical treatment." Cancer 2000;89:1999-2005.

Active research studies in 2000